A
Price
$125.94
Change
-$0.39 (-0.31%)
Updated
Sep 23 closing price
Capitalization
35.7B
68 days until earnings call
TMO
Price
$469.75
Change
-$5.24 (-1.10%)
Updated
Sep 23 closing price
Capitalization
177.38B
28 days until earnings call
Interact to see
Advertisement

A vs TMO

Header iconA vs TMO Comparison
Open Charts A vs TMOBanner chart's image
Agilent Technologies
Price$125.94
Change-$0.39 (-0.31%)
Volume$1.28M
Capitalization35.7B
Thermo Fisher Scientific
Price$469.75
Change-$5.24 (-1.10%)
Volume$3.24M
Capitalization177.38B
A vs TMO Comparison Chart in %
Loading...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. TMO commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Hold and TMO is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (A: $125.94 vs. TMO: $469.75)
Brand notoriety: A and TMO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 79% vs. TMO: 138%
Market capitalization -- A: $35.7B vs. TMO: $177.38B
A [@Medical Specialties] is valued at $35.7B. TMO’s [@Medical Specialties] market capitalization is $177.38B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $10.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 0 FA rating(s) are green whileTMO’s FA Score has 0 green FA rating(s).

  • A’s FA Score: 0 green, 5 red.
  • TMO’s FA Score: 0 green, 5 red.
According to our system of comparison, A is a better buy in the long-term than TMO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 4 TA indicator(s) are bullish while TMO’s TA Score has 3 bullish TA indicator(s).

  • A’s TA Score: 4 bullish, 6 bearish.
  • TMO’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, A is a better buy in the short-term than TMO.

Price Growth

A (@Medical Specialties) experienced а -0.98% price change this week, while TMO (@Medical Specialties) price change was -2.29% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.43%. For the same industry, the average monthly price growth was +3.59%, and the average quarterly price growth was +23.15%.

Reported Earning Dates

A is expected to report earnings on Dec 01, 2025.

TMO is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Medical Specialties (+0.43% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TMO($177B) has a higher market cap than A($35.7B). A has higher P/E ratio than TMO: A (29.43) vs TMO (27.17). A YTD gains are higher at: -5.856 vs. TMO (-9.452). A has more cash in the bank: 1.54B vs. TMO (1.12B). A has less debt than TMO: A (3.41B) vs TMO (35.2B).
ATMOA / TMO
Capitalization35.7B177B20%
EBITDA1.8BN/A-
Gain YTD-5.856-9.45262%
P/E Ratio29.4327.17108%
Revenue6.79BN/A-
Total Cash1.54B1.12B137%
Total Debt3.41B35.2B10%
FUNDAMENTALS RATINGS
A vs TMO: Fundamental Ratings
A
TMO
OUTLOOK RATING
1..100
7652
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
68
Overvalued
PROFIT vs RISK RATING
1..100
7184
SMR RATING
1..100
4558
PRICE GROWTH RATING
1..100
5360
P/E GROWTH RATING
1..100
4582
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (53) in the Biotechnology industry is in the same range as TMO (68) in the Medical Specialties industry. This means that A’s stock grew similarly to TMO’s over the last 12 months.

A's Profit vs Risk Rating (71) in the Biotechnology industry is in the same range as TMO (84) in the Medical Specialties industry. This means that A’s stock grew similarly to TMO’s over the last 12 months.

A's SMR Rating (45) in the Biotechnology industry is in the same range as TMO (58) in the Medical Specialties industry. This means that A’s stock grew similarly to TMO’s over the last 12 months.

A's Price Growth Rating (53) in the Biotechnology industry is in the same range as TMO (60) in the Medical Specialties industry. This means that A’s stock grew similarly to TMO’s over the last 12 months.

A's P/E Growth Rating (45) in the Biotechnology industry is somewhat better than the same rating for TMO (82) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than TMO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATMO
RSI
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 2 days ago
45%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
56%
Bullish Trend 1 day ago
42%
Momentum
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 1 day ago
53%
MACD
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
57%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 1 day ago
59%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
60%
Bearish Trend 1 day ago
63%
Advances
ODDS (%)
Bullish Trend 8 days ago
62%
Bullish Trend 19 days ago
61%
Declines
ODDS (%)
Bearish Trend 15 days ago
60%
Bearish Trend 1 day ago
64%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
53%
Bullish Trend 1 day ago
68%
Aroon
ODDS (%)
Bullish Trend 1 day ago
61%
Bearish Trend 1 day ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MBND27.43N/A
N/A
SPDR® Nuveen Municipal Bond ETF
AVSE63.83-0.16
-0.24%
Avantis Responsible Emerging Mkts Eq ETF
CGMM28.51-0.07
-0.24%
Capital Group U.S. Small & Mid Cap ETF
HFRO6.77-0.02
-0.32%
Highland Opportunities and Income Fund
QLD136.44-1.87
-1.35%
ProShares Ultra QQQ

A and

Correlation & Price change

A.I.dvisor indicates that over the last year, A has been closely correlated with MTD. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if A jumps, then MTD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To A
1D Price
Change %
A100%
-0.31%
MTD - A
85%
Closely correlated
-0.08%
TMO - A
79%
Closely correlated
-1.10%
WAT - A
79%
Closely correlated
-1.08%
RVTY - A
78%
Closely correlated
-0.65%
DHR - A
75%
Closely correlated
-0.39%
More

TMO and

Correlation & Price change

A.I.dvisor indicates that over the last year, TMO has been closely correlated with A. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if TMO jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TMO
1D Price
Change %
TMO100%
-1.10%
A - TMO
79%
Closely correlated
-0.31%
DHR - TMO
79%
Closely correlated
-0.39%
MTD - TMO
77%
Closely correlated
-0.08%
RVTY - TMO
74%
Closely correlated
-0.65%
BRKR - TMO
69%
Closely correlated
+1.77%
More